Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- FMC-NA is Company of Choice to Treat Veterans Posted 09-13-2022
- Outset Gets FDA Green Light Posted 08-11-2022
- Baxter Showcases Kidney Care Products Posted 06-10-2022
- DaVita and Medtronic to Launch New Kidney Tech Company Posted 06-10-2022